-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TouZA5Yt1e2bG+w2+0chL1WfgoWCxhcxgobXvNUcGj6stoCtUJUCLjz3WrYJ9Q1d gHJ5YJKSgtGJ2JwkxTRvwA== 0001184430-04-000007.txt : 20040205 0001184430-04-000007.hdr.sgml : 20040205 20040205132225 ACCESSION NUMBER: 0001184430-04-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040203 FILED AS OF DATE: 20040205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEOSE TECHNOLOGIES INC CENTRAL INDEX KEY: 0000877902 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133549286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 102 WITMER RD CITY: HORSHAM STATE: PA ZIP: 19044 BUSINESS PHONE: 2154415890 MAIL ADDRESS: STREET 1: 102 WITMER ROAD CITY: HORSHAM STATE: PA ZIP: 19044 FORMER COMPANY: FORMER CONFORMED NAME: NEOSE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLARKE C BOYD CENTRAL INDEX KEY: 0001182504 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27718 FILM NUMBER: 04569448 BUSINESS ADDRESS: STREET 1: C/O NEOSE TECHNOLGIES INC STREET 2: 102 WITMER ROAD CITY: HORSHAM STATE: PA ZIP: 19044 BUSINESS PHONE: 2153159000 MAIL ADDRESS: STREET 1: C/O NEOSE TECHNOLOGIES INC STREET 2: 102 WITMER ROAD CITY: HORSHAM STATE: PA ZIP: 19044 4 1 edgardoc.xml PRIMARY DOCUMENT X0201 4 2004-02-03 0 0000877902 NEOSE TECHNOLOGIES INC NTEC 0001182504 CLARKE C BOYD C/O NEOSE TECHNOLOGIES INC 102 WITMER ROAD HORSHAM PA 19044 1 1 0 0 President & CEO Incentive Stock Option (right to buy) 11.68 2004-02-03 4 A 0 17122 11.68 A 2014-02-03 Common Stock 17122 17122 D Non-Qualified Stock Option (right to buy) 11.68 2004-02-03 4 A 0 182878 11.68 A 2014-02-03 Common Stock 182878 182878 D Grant to reporting person of option to buy 17,122 shares, of which 8,561 become exercisable on February 3, 2007 and 8,561 become exercisable on February 3, 2008. Grant to reporting person of option to buy 182,878 shares, of which 50,000 become exercisable on February 3, 2005, 50,000 become exercisable on February 3, 2006, 41,439 become exercisable on February 3, 2007 and 41,439 become exerisable on February 3, 2008. C. Boyd Clarke 2004-02-05 -----END PRIVACY-ENHANCED MESSAGE-----